×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Effective Leadership in Hybrid Team Between West and East Asia in New Drug Development
Session Chair(s)
Atsushi Tsukamoto, PhD, MSc
Corporate Officer, Head is Therapeutic Area Strategies
Daiichi Sankyo, United States
In this forum, we will discuss key success factors and common gaps in a West and East Asian hybrid team in drug development. Participants will learn practical tips that can be used immediately for successful hybrid team leadership and management.
Learning Objective : Effectively lead and manage a West and East Asian hybrid drug development team; Discuss various leadership models in a hybrid team; Discuss strengths and weaknesses of a hybrid team, especially a West and East Asian hybrid; Identify success factors for Western colleagues to effectively work with Korean, Chinese and Japanese organizations in a global environment.
Speaker(s)
Panelist
Robert Hilke, MA
Hilke Communications Corporation, Japan
Chief Executive Officer
Panelist
Gareth Julian Monteath, PhD, MBA, MS
Link Global Solution Inc., Japan
Executive Director
Panelist
Atsushi Tsukamoto, PhD, MSc
Daiichi Sankyo, United States
Corporate Officer, Head is Therapeutic Area Strategies
Have an account?